Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

When is the expected fda decision date for apotex's ruxolitinib resubmission?
Drug patent watch trametinib?
Norcuron generic name?
How to apply for vascepa's patient assistance?
Motegrity ingredients?

Lamictal sold by?

See the DrugPatentWatch profile for Lamictal

Who sells Lamictal (lamotrigine) in the US?

Lamictal is marketed and sold by GlaxoSmithKline (GSK) in the United States. The brand name is Lamictal and the active ingredient is lamotrigine [1].

Is Lamictal also available as a generic? Who makes it?

Yes. Generic lamotrigine is sold by multiple manufacturers through pharmacy supply chains, but the brand-name product “Lamictal” is associated with GSK [1].

What does it mean if a pharmacy lists a different “manufacturer”?

Pharmacies may show the specific generic manufacturer for the product dispensed, even though the medication name your prescription uses may be “lamotrigine.” That doesn’t change the drug’s active ingredient; it changes the company producing the product [1].

Sources

[1] https://www.gsk.com/en-gb/products/lamictal/

Prescribing Information Alignment Report

Executive Summary

Overall Alignment: Unable to Assess

The provided AI claims focus on brand/generic manufacturer and pharmacy listing behavior, not on FDA prescribing information content. The input includes excerpts from Lamictal labeling related to serious skin rashes, but no label text excerpts relevant to the manufacturer/dispensing claims. Therefore, alignment cannot be verified against prescribing information for these claims.

Alignment Scorecard

Category	Status	Notes
Indication	Unable to Assess	Claims provided are about marketing/manufacturer listing, not indications.
Patient Population	Not Addressed	No patient population statements in the provided claims.
Dosage & Administration	Not Addressed	No dosage statements in the provided claims.
Contraindications	Not Applicable	No contraindication-related claims provided.
Warnings & Precautions	Not Addressed	Provided label excerpts about rash were not connected to the claims about manufacturer listing.
Drug Interactions	Not Applicable	No interaction claims provided.
Adverse Reactions	Not Addressed	No adverse reaction claims provided.
Monitoring	Not Applicable	No monitoring claims provided.
Administration Instructions	Not Applicable	No administration instruction claims provided.
Limitations of Use	Not Applicable	No limitations-of-use claims provided.
Special Populations	Not Addressed	No special population claims provided.

Key Findings

All provided AI claims relate to brand ownership/marketing and pharmacy manufacturer listing/dispensing behavior.
The supplied authoritative labeling excerpts concern serious skin rash warnings (boxed warning/section 5.1) and do not address brand manufacturer attribution or pharmacy listing mechanics.
As a result, none of the manufacturer/dispensing claims can be verified or refuted using the provided prescribing-information excerpts.

Claim-by-Claim Assessment

AI Claim	Assessment	Supporting Evidence	Potential Impact
Lamictal is marketed and sold by GlaxoSmithKline (GSK) in the United States.	Cannot Determine	No relevant prescribing-information excerpt provided that states the marketer/seller in the U.S.	Informational
Lamictal is the brand name for lamotrigine.	Cannot Determine	No label excerpt provided explicitly linking the brand name to the active ingredient in the context of these claims (although this is generally expected, it is not verifiable from provided text).	Informational
Generic lamotrigine is sold by multiple manufacturers through pharmacy supply chains.	Cannot Determine	No prescribing-information excerpt provided describing generic manufacturers or pharmacy supply-chain listing practices.	Informational
The brand-name product Lamictal is associated with GSK.	Cannot Determine	No provided label excerpt establishes corporate association/brand sponsor.	Informational
A pharmacy may list the specific generic manufacturer for the dispensed product.	Cannot Determine	No prescribing-information excerpt provided describing pharmacy display practices for generic manufacturer identity.	Informational
If a pharmacy lists a different manufacturer, it changes the company producing the product.	Cannot Determine	No labeling excerpt provided that discusses whether pharmacy manufacturer listing corresponds to the producing company.	Informational
If a pharmacy lists a different manufacturer, it does not change the drug’s active ingredient.	Cannot Determine	No prescribing-information excerpt provided that addresses this specific pharmacy-manufacturer/active-ingredient relationship.	Informational

Important Omissions

No FDA label excerpts were provided that contain statements about brand sponsor/marketer, corporate association, or generic manufacturer labeling/dispensing practices.
The provided label excerpts are specific to serious skin rash warnings and are not mapped to the manufacturer/pharmacy listing claims.

Unsupported / Hallucinated Content

None identified as contradicted or unsupported by FDA labeling, because the provided authoritative excerpts do not cover the content of these claims.

Potential Patient Safety Concerns

The evaluated claims are about marketing/manufacturer listing rather than dosing, contraindications, warnings, or administration. No direct patient safety implications can be assessed from the provided excerpts. However, claims about drug identity should be verified using the actual product label and dispensing information.

Overall Assessment

The AI response content provided here is not verifiable against the supplied FDA prescribing-information excerpts. While Lamictal labeling excerpts about serious skin rashes were included, they do not support or refute any of the manufacturer/brand/pharmacy listing claims. Therefore, overall alignment for these specific claims is Unable to Assess based on the provided evidence.

Brand Assessment

GEO Score

Visibility

Mentioned

Ranking

Sentiment

Recommendation Status

mentioned only

Brand Perception

Best Known For

The brand name is Lamictal and the active ingredient is lamotrigine

Core Claims

Lamictal is marketed and sold by GlaxoSmithKline (GSK) in the United States.
Lamictal is associated with GSK.
The brand name is Lamictal and the active ingredient is lamotrigine.

Differentiators

Brand-name Lamictal is associated with GSK.
Active ingredient is lamotrigine.

Pricing Perception: Not Mentioned

Competitors Mentioned

Company	Visibility	Sentiment	Rank	Recommended
GlaxoSmithKline	62%	55	#1	No